| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,595 |
37,750 |
$3.48M |
| 99442 |
|
19,658 |
18,745 |
$1.55M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,698 |
6,439 |
$879K |
| 97802 |
|
13,509 |
12,932 |
$407K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,255 |
2,253 |
$375K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,564 |
5,468 |
$370K |
| 99441 |
|
5,550 |
5,280 |
$305K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,027 |
2,027 |
$264K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,925 |
1,924 |
$202K |
| 81003 |
|
22,376 |
21,916 |
$175K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,376 |
1,369 |
$170K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,346 |
1,346 |
$168K |
| 81025 |
|
13,394 |
13,168 |
$161K |
| 99058 |
|
7,132 |
7,013 |
$155K |
| 90670 |
|
1,523 |
1,523 |
$133K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,702 |
1,702 |
$125K |
| 90710 |
|
669 |
669 |
$106K |
| 82948 |
|
8,618 |
8,074 |
$98K |
| 90649 |
|
901 |
901 |
$97K |
| 92551 |
|
4,468 |
4,450 |
$87K |
| 99173 |
|
12,891 |
12,886 |
$87K |
| 85018 |
|
6,949 |
6,868 |
$82K |
| 90734 |
|
674 |
674 |
$69K |
| G9920 |
Screening performed and negative |
2,311 |
2,305 |
$67K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
650 |
598 |
$36K |
| 90633 |
|
958 |
958 |
$28K |
| 99215 |
Prolong outpt/office vis |
131 |
127 |
$26K |
| 90647 |
|
1,168 |
1,167 |
$24K |
| 90736 |
|
105 |
105 |
$23K |
| 93000 |
|
1,367 |
1,367 |
$23K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,973 |
1,968 |
$23K |
| 99205 |
Prolong outpt/office vis |
70 |
70 |
$22K |
| 97803 |
|
2,623 |
2,560 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
283 |
280 |
$21K |
| 90723 |
|
878 |
878 |
$21K |
| 99000 |
|
6,489 |
6,200 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
6,462 |
6,173 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
87 |
87 |
$19K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,011 |
3,011 |
$18K |
| 96127 |
|
5,560 |
5,552 |
$15K |
| 87430 |
|
1,572 |
1,563 |
$15K |
| 90686 |
|
809 |
809 |
$15K |
| 99381 |
|
119 |
118 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,102 |
1,093 |
$12K |
| 90700 |
|
435 |
435 |
$12K |
| 90715 |
|
494 |
494 |
$11K |
| 99443 |
|
114 |
113 |
$11K |
| 99383 |
|
122 |
122 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
374 |
372 |
$10K |
| 99385 |
|
53 |
53 |
$9K |
| 90680 |
|
323 |
323 |
$6K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,269 |
1,269 |
$6K |
| 83655 |
|
510 |
509 |
$5K |
| 99384 |
|
29 |
29 |
$5K |
| 78456 |
|
29 |
29 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
159 |
159 |
$4K |
| 90696 |
|
129 |
129 |
$4K |
| 57410 |
|
212 |
210 |
$3K |
| 90837 |
Psychotherapy, 53 minutes with patient |
27 |
12 |
$3K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
176 |
176 |
$3K |
| 86580 |
|
88 |
88 |
$2K |
| 90674 |
|
137 |
137 |
$1K |
| 88142 |
|
123 |
123 |
$1K |
| 90688 |
|
35 |
35 |
$872.90 |
| 90713 |
|
13 |
13 |
$845.00 |
| 20553 |
|
140 |
136 |
$765.00 |
| 20552 |
|
49 |
49 |
$629.88 |
| 90656 |
|
12 |
12 |
$302.94 |
| 99050 |
|
107 |
104 |
$300.00 |
| 3077F |
|
547 |
519 |
$245.84 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
1,018 |
1,018 |
$164.72 |
| 81007 |
|
16 |
16 |
$44.64 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,594 |
1,587 |
$41.47 |
| 90461 |
|
921 |
917 |
$36.57 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
692 |
692 |
$30.35 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,613 |
1,612 |
$30.35 |
| 3725F |
|
619 |
619 |
$25.00 |
| 99188 |
|
15 |
15 |
$0.01 |
| 36416 |
|
306 |
305 |
$0.01 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
61 |
$0.00 |
| 3078F |
|
1,109 |
1,089 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
191 |
191 |
$0.00 |
| 98966 |
|
15 |
15 |
$0.00 |
| 90648 |
|
31 |
31 |
$0.00 |
| 99201 |
|
34 |
34 |
$0.00 |
| 90746 |
|
94 |
94 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
67 |
67 |
$0.00 |
| 3046F |
|
15 |
14 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
15 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
13 |
$0.00 |
| 3051F |
|
13 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
665 |
656 |
$0.00 |
| 3079F |
|
589 |
572 |
$0.00 |
| 3044F |
|
907 |
893 |
$0.00 |
| 3074F |
|
984 |
971 |
$0.00 |
| 3075F |
|
246 |
243 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
380 |
380 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
232 |
221 |
$0.00 |
| 90732 |
|
29 |
29 |
$0.00 |
| 90632 |
|
18 |
18 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21 |
20 |
$0.00 |
| 86804 |
|
16 |
16 |
$0.00 |
| 90677 |
|
96 |
96 |
$0.00 |
| 3080F |
|
31 |
30 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$0.00 |